Sunday, May 15, 2016

Achievements of India in Science, Engineering and Technology - 2016

15 May 2016
Indian Railways goes green as solar-powered train set for trial

Indian Railways’ First Solar Train Prototype Unveiled in Jodhpur

A Book Published by Institution of Engineers, India

Achievement of Engineering in India in New Milennium

September 2015

15 September - Engineers' Day in India

IIT-B - 10-inch netbook  costing less than $100
700g - Equipped with a 1GHz dual core processor, 1GB of memory and 8GB Nand Flash - Wifi enabled.

April 2015

State of the art Scorpene submarine which has superior stealth and has precision guided weapons was undocked on 6 April 2015 by Defence Minister Manohar Parikkar at Mazagon Dock Limited.  MDL has to make five more of these submarines.

January 2015

The 50-tonne inter-continental ballistic missile, Agni-V capable going up to 5000 Km, the country's first such missile, was tested for the first time in a canisterised version. This was the third test-firing of the three-stage missile but first time in canister version.

India's first successful double hand transplant

Indian doctors have registered a rare feat by conducting India's first successful double hand transplant in a 16-hour-long surgery.
It was conducted at Amrita Institute of Medical Science in Kochi on a 30-year-old train accident victim, who received both hands of a 24-year-old road accident victim.

This transplant has put the Indian scientific community among the league of a few developed nations in the field of composite tissue allotransplant.
Only 110 successful hand transplants have been conducted so far in the US, European countries, China and Australia.

The entire expenses for the transplant were borne by the Mata Amritanandamayi Math.

BMC Engineers repaired giant sewage pump check valve giving the ability to repair valves and prolong their life for some more years saving crores of rupees.
News reported in Mumbai Mirror, 7 January 2015
Reported by

Aurobindo Pharma and Lupin got FDA, USA approval for Valsartan

Aurobindo Pharma on Tuesday announced that the company has received final approval from the U.S. Food & Drug Administration to manufacture and market Valsartan Tablets USP, 40mg, 80mg, 160mg and 320mg (ANDA 202223).

Valsartan Tablets are the generic equivalent to Novartis' Diovan Tablets, which is indicated for the treatment of hypertension to lower blood pressure. The product has a market size of approximately $2 billion for the 12 months ending October 2014, according to IMS.

January 06, 2015: Pharma Major Lupin Limited announced today that its US subsidiary, Lupin Pharmaceuticals Inc. (collectively Lupin) has launched its Valsartan Tablets USP, 40 mg, 80 mg, 160 mg and 320 mg, the generic for Novartis Pharmaceuticals Corporation’s (Novartis) Diovan® Tablets 40 mg, 80 mg, 160 mg and 320 mg strengths, having received final approval from the United States Food and Drug Administration (FDA).
Lupin's Valsartan Tablets 40 mg, 80 mg, 160 mg and 320 mg are the AB rated generic equivalent of Novartis’s Diovan® Tablets and is indicated for the treatment of hypertension and heart failure.
Diovan® Tablets had annual U.S sales of US$ 2.08 billion (IMS MAT September, 2014).

Updated 26 Mar 2016, 12 Sep 2015

No comments:

Post a Comment